Clinical trial
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in…
NCT00307502 · Germans Trias i Pujol Hospital, Other · Completed
Key facts
| NCT number | NCT00307502 |
|---|---|
| Title | Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV |
| Official title | Cross-sectional Study for the Characterisation of the Pharmacokinetic Parameters of Protease Inhibitors and Non-nucleoside Analog Reverse Transcriptase Inhibitors in the Spanish Population of HIV-infected Subjects |
| Lead sponsor | Germans Trias i Pujol Hospital, Other |
| Collaborators | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine, Efavirenz, Indinavir/ritonavir, Nelfinavir, Saquinavir/ritonavir, Lopinavir/ritonavir, Atazanavir, Atazanavir/ritonavir, Fos-amprenavir/ritonavir, Tipranavir/ ritonavir and 1 more |
| Enrollment | 675 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Mar 28, 2006 |
| Last update posted | Dec 4, 2019 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: